Drugs of Abuse Screen - Cocaine and Metabolites - Urine

0090306
copy
 

Copy Utility


emailprint
Example Reports
Negative
Positive
Ordering Recommendation

Useful for general screening in contexts of compliance and/or abuse.

Mnemonic
U COC
Methodology

Enzyme Immunoassay

Performed

Sun-Sat

Reported

Within 24 hours

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect

Random urine.

Specimen Preparation

Mix well. Transfer 4 mL urine to an ARUP Standard Transport Tube. (Min: 1 mL)

Storage/Transport Temperature

Refrigerated. Also acceptable: Room temperature or frozen.

Unacceptable Conditions
Remarks
Stability

Ambient: 1 week; Refrigerated: 5 days; Frozen: 3 years

Reference Interval

Negative

Interpretive Data

This test detects benzoylecgonine and m-hydroxybenzoylecgonine in urine when the concentration is greater than the cutoff of 300 ng/mL. This is a screening test, results are unconfirmed. Unconfirmed results are to be used for medical (treatment) purposes only.

Compliance Category

FDA

Note
Hotline History
N/A
CPT Codes

80307

Are you an ARUP Client? Click here for your pricing.
Components
Component Test Code* Component Chart Name LOINC
0090306 Cocaine and Metabolites 14314-9
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Cocaine tox screen
  • Cocaine urine tox screen
  • Substance abuse screening
Drugs of Abuse Screen - Cocaine and Metabolites - Urine